Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
INOVIO Announces Pricing of Public Offering of Common Stock

, /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases,...

INO : 9.10 (-6.38%)
INOVIO Announces Proposed Public Offering of Common Stock

, /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases,...

INO : 9.10 (-6.38%)
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and HPV-associated...

INO : 9.10 (-6.38%)
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China

and SUZHOU, , /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer,...

INO : 9.10 (-6.38%)
February 2021 Options Now Available For Inovio Pharmaceuticals (INO)

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the February 2021 expiration.

INO : 9.10 (-6.38%)
Zika Virus Vaccines Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The research report titled Zika Virus Vaccines offers comprehensive information on key driving factors, pricing analysis, market growth trends, brand positioning, competitive landscape, product usage and...

CERS : 7.23 (-0.75%)
GSK : 37.78 (-0.63%)
IMV.TO : 4.51 (-2.59%)
INO : 9.10 (-6.38%)
XON : 4.65 (-4.12%)
NLNK : 0.8900 (-12.75%)
TKPYY : 16.5900 (-0.90%)
Company News for Dec 28, 2020

Companies In The News Are: BUD, APO, INO, GOOGL, INTC, CLDR

INTC : 62.46 (+6.46%)
BUD : 67.81 (-0.72%)
APO : 47.81 (-0.50%)
GOOGL : 1,884.15 (+0.22%)
INO : 9.10 (-6.38%)
CLDR : 14.09 (-2.22%)
6 Biotech/Drug Stocks Up Manifold in 2020 Thanks to COVID-19

We discuss six biotech/drug stocks, NVAX, VXRT, MRNA, TBIO, INO and BNTX that have more than doubled in 2020 on the back of their progress in coronavirus vaccine development.

MRNA : 132.98 (+6.26%)
NVAX : 122.40 (-2.12%)
TBIO : 22.53 (+1.21%)
INO : 9.10 (-6.38%)
BNTX : 105.43 (+2.13%)
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI.

COCP : 2.21 (-5.96%)
INO : 9.10 (-6.38%)
ODT : 19.44 (-0.46%)
GEVO : 9.30 (+7.27%)
VUZI : 10.90 (-2.42%)
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced...

INO : 9.10 (-6.38%)
Optimism Building As Additional COVID-19 Vaccines Are Expected to be Released Globally

PALM BEACH,  Fla., /PRNewswire/ -- Since the global outbreak that triggered the pandemic, scientists around the world have been working on potential treatments and vaccines for the new coronavirus disease...

BIOV.CN : 0.180 (unch)
LMNGF : 0.1400 (-5.21%)
MRNA : 132.98 (+6.26%)
PFE : 36.48 (-0.05%)
BNTX : 105.43 (+2.13%)
INO : 9.10 (-6.38%)
SRNE : 9.98 (-0.50%)
Are Options Traders Betting on a Big Move in Inovio Pharmaceuticals (INO) Stock?

Investors need to pay close attention to Inovio Pharmaceuticals (INO) stock based on the movements in the options market lately.

INO : 9.10 (-6.38%)
Global Market Outlook for the Coronavirus Vaccine Market to 2027, Featuring Moderna Inc, GeoVax, Inovio Pharmaceuticals and more

, /PRNewswire/ -- The report has been added to offering.

INO : 9.10 (-6.38%)
NNVC : 3.83 (+10.06%)
NVAX : 122.40 (-2.12%)
Thinking about buying stock in Tcr2 Therapeutics, Inovio Pharmaceuticals, BioLineRx, Plug Power, or Arbutus Biopharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TCRR, INO, BLRX, PLUG, and ABUS.

ABUS : 3.96 (-3.65%)
INO : 9.10 (-6.38%)
TCRR : 29.02 (-5.53%)
BLRX : 2.53 (+3.27%)
PLUG : 63.69 (+1.90%)
INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA) and the Department of Defense's (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced...

INO : 9.10 (-6.38%)
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China

and SUZHOU, , /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer,...

INO : 9.10 (-6.38%)
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients

, /PRNewswire/ -- All around the globescientists are working hard to develop effective treatments, therapies and vaccines to halt the COVID-19 pandemic. Therapies that are under investigation include...

CTXR : 1.2500 (-5.66%)
MRNA : 132.98 (+6.26%)
INO : 9.10 (-6.38%)
PFE : 36.48 (-0.05%)
AZN : 52.55 (+0.59%)
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and diseases...

INO : 9.10 (-6.38%)
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

, /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today...

INO : 9.10 (-6.38%)
Thinking about buying stock in Sutro Biopharma, BioCryst Pharmaceuticals, Inovio Pharmaceuticals, Cocrystal Pharma, or Clean Energy Fuels?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for STRO, BCRX, INO, COCP, and CLNE.

BCRX : 9.15 (-1.03%)
CLNE : 10.18 (-3.96%)
COCP : 2.21 (-5.96%)
INO : 9.10 (-6.38%)
STRO : 26.17 (-0.61%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar